Event Calendar
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
World Sustainable Energy Days 2025
Starts in 1 month from now
LocationWels (Austria)
Staying on target for climate neutrality is a key challenge in changing political and economic frameworks. The aim is clear: no more fossil fuels! Becoming the first climate-neutral continent will offer Europe a key competitive advantage and increase our resilience in all sectors. In 2025, the World Sustainable Energy Days (WSED), organised by OÖ Energiesparverband, will show how to gain momentum and present policies, programmes and innovation to reach our goals together.
The World Sustainable Energy Days (WSED) are an annual conference on the energy transition and climate neutrality with over 650 participants from more than 60 countries. I actually combines the following conferences:
- European Pellet Conference
- Energy Efficiency Conference
- Young Energy Researchers
- Energy Efficiency Policy
- Industrial Energy Transition
- Smart E-Mobility
Read more about the program and registration here.
The conference is not free of charge.
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Event calendar
37 upcoming events view event calendarSecurity AI, data & cloud Cybersecurity Defence Space
Info day on the DEFRA call 2025
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
